ArticleOncogene2024
GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma.
Peiyi Xie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it